AUPH earnings: next report 2026-07-30, real EPS beat/miss history, analyst consensus Buy, P/E 6.84. Updated 2026-07-23.
Aurinia Pharmaceuticals (AUPH) Research Hub
Aurinia Pharmaceuticals (AUPH) trades on NASDAQ, CA in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 16.1 USD (-0.92%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 6.84, market cap 1.97B. This hub links to the full technical, earnings and options research available for AUPH.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, CA |
| Last close | 16.1 USD (-0.92%) |
| 52-week range | 14.36 USD – 19.25 USD |
| Trend regime | Range |
| 14-day RSI | 53.7 (Neutral) |
| Trailing P/E | 6.84 |
| Market cap | 1.97B |
| Dividend yield | 0.00% |
| Next earnings | 2026-07-30 |
Available research for AUPH
Covered Call on AUPH: how it works, illustrative setup around the real 16.1 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on AUPH: how it works, illustrative setup around the real 16.1 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on AUPH: how it works, illustrative setup around the real 16.1 USD price, max profit/loss, breakeven and when to use it. Educational.
AUPH technical analysis: range, last 16.1 USD, RSI 53.7, 52w range 14.36 USD–19.25 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is AUPH in?
Aurinia Pharmaceuticals (AUPH) is classified under Healthcare (Biotechnology), listed on NASDAQ, CA.
Is AUPH in an uptrend or downtrend?
As of 2026-09-11, AUPH is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is AUPH's trailing P/E ratio?
AUPH's trailing P/E is 6.84, with a market cap of 1.97B. See the earnings research page for full valuation detail.
When does AUPH next report earnings?
AUPH is next scheduled to report earnings on 2026-07-30, with a consensus EPS estimate of 0.19 USD.